Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Lobe Sciences Ltd
(CSE:
LOBE
)
0.0500
UNCHANGED
Streaming Delayed Price
Updated: 3:25 PM EDT, Oct 10, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Lobe Sciences Ltd
< Previous
1
2
Next >
Psychedelic-Derived Medicines for Neurologic Conditions Fueling Large Revenue Growth in Projected $4 Billion Dollar Industry
January 26, 2023
EQNX::TICKER_START (OTCQB:LOBEF),(NASDAQ:ATAI),(NASDAQ:CMPS),(NYSE:CYBN),(NASDAQ:MNMD) EQNX::TICKER_END
Via
FinancialNewsMedia
Topics
Economy
Lobe Sciences, Ltd. Enters Collaborative Clinical Research Agreement with Integrative Headache Medicine of New York to Study the Effects of L-130 in the Treatment of Chronic Cluster Headache
January 26, 2023
Dr. Lauren R. Natbony to be Principal investigator Vancouver, BC – January 26, 2023 — Lobe Sciences Ltd. (OTCQB: LOBEF) (CSE: LOBE) (“Lobe” or the “Company”), a North American Biopharmaceutical company...
Via
FinancialNewsMedia
Lobe Sciences Ltd (LOBEF) increases its portfolio with several new chemical entities (NCEs)
January 19, 2023
Via
AB Newswire
Topics
Intellectual Property
Lobe Sciences Announces Incorporation of Australian Subsidiary
September 23, 2022
Vancouver, British Columbia--(Newsfile Corp. - September 23, 2022) - Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBEF) ("Lobe" or the "Company"),...
Via
Newsfile
Lobe Sciences Announces Closing of Private Placement
September 08, 2022
Vancouver, British Columbia--(Newsfile Corp. - September 8, 2022) - Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBEF) ("Lobe" or the "Company"),...
Via
Newsfile
Lobe Sciences and Cantheon Capital Enter into Exclusive Investment Agreement to Fund $1.5M USD Toward Clinical Trials in Australia
September 01, 2022
Vancouver, British Columbia--(Newsfile Corp. - September 1, 2022) - Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBEF) ("Lobe" or the "Company"),...
Via
Newsfile
Topics
Cannabis
Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBEF) Featured in Coverage of Planet MicroCap’s Virtual Investor Conference
April 19, 2022
Via
Investor Brand Network
Lobe Sciences Ltd. (OTCQB: LOBEF) (CSE: LOBE) Featured in Coverage of Investor Summit Group’s Q1 Virtual Event
March 07, 2022
Via
Investor Brand Network
Lobe Sciences to Participate at the Advances in Mental Health Psychedelics and Non-Psychedelics Conference
September 15, 2021
Vancouver, British Columbia--(Newsfile Corp. - September 15, 2021) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or the...
Via
Newsfile
Lobe Sciences Provides Corporate Update to Investors and Stakeholders
September 13, 2021
Vancouver, British Columbia--(Newsfile Corp. - September 13, 2021) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or the...
Via
Newsfile
Topics
Cannabis
Intellectual Property
Lobe Sciences to Present At H.C. Wainwright 23rd Annual Global Investment Conference
September 10, 2021
Vancouver, British Columbia--(Newsfile Corp. - September 10, 2021) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or the...
Via
Newsfile
Lobe Sciences Appoints Albert "Skip" Rizzo, Ph.D to Scientific Advisory Board
August 23, 2021
Director, Medical Virtual Reality - Institute for Creative Technologies Research Professor - Dept. of Psychiatry and School of Gerontology University...
Via
Newsfile
Lobe Sciences Appoints Gilberto Jesús Mendoza, President of the World Boxing Association, to Advisory Board
July 13, 2021
Vancouver, British Columbia--(Newsfile Corp. - July 13, 2021) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or the...
Via
Newsfile
Lobe Sciences Clarifies Recent Promotional Activities at Request of OTC Markets
July 02, 2021
Vancouver, British Columbia--(Newsfile Corp. - July 2, 2021) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or the...
Via
Newsfile
Lobe Sciences Appoints Charles Grob, MD to Scientific Advisory Board
June 28, 2021
Investigator, The Lundquist InstituteProfessor of Psychiatry & Biobehavioral Sciences and Pediatrics, David Geffen School of Medicine at UCLA Vancouver, British...
Via
Newsfile
Lobe Sciences to Present at H.C. Wainwright Psychedelics in Psychiatry and Beyond Virtual Conference
June 15, 2021
Vancouver, British Columbia--(Newsfile Corp. - June 15, 2021) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or the...
Via
Newsfile
Lobe Sciences to Present at the LD Micro Invitational XI
June 07, 2021
Vancouver, British Columbia--(Newsfile Corp. - June 7, 2021) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or the...
Via
Newsfile
Lobe Sciences Secures Production and Supply Agreement for Vitamind Consumer Packaged Goods Products
May 19, 2021
Vancouver, British Columbia--(Newsfile Corp. - May 19, 2021) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or...
Via
Newsfile
Lobe Sciences to Present at the Benzinga Global Small Cap Conference
May 06, 2021
Vancouver, British Columbia--(Newsfile Corp. - May 6, 2021) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or the "Company") is...
Via
Newsfile
Lobe Sciences Acquires Vitamind Line of Wellness Products
May 04, 2021
Vancouver, British Columbia--(Newsfile Corp. - May 4, 2021) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or the "Company") is...
Via
Newsfile
Topics
Intellectual Property
Lobe Sciences Announces Filing of PCT Application
April 29, 2021
Vancouver, British Columbia--(Newsfile Corp. - April 29, 2021) - Lobe Sciences Ltd. ("Lobe" or the "Company") (CSE: LOBE) (OTC Pink:...
Via
Newsfile
Topics
Intellectual Property
Lobe Sciences Enters into LOI with Core One Labs to Form a Joint Venture for the Clinical Development of Biosynthetic Psilocybin
April 28, 2021
Vancouver, British Columbia--(Newsfile Corp. - April 28, 2021) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or the...
Via
Newsfile
Lobe Sciences Enters into Joint Venture with Virtual Psychedelics Incorporated to Develop Multi-Sensory Pods for Clinical Psychedelic Use
April 27, 2021
Vancouver, British Columbia--(Newsfile Corp. - April 27, 2021) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or...
Via
Newsfile
Topics
Intellectual Property
Lobe Sciences Appoints Benjamin Kelmendi, MD from Yale University to Scientific Advisory Board
April 20, 2021
Vancouver, British Columbia--(Newsfile Corp. - April 20, 2021) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or the...
Via
Newsfile
Lobe Sciences to Present at the Emerging Growth Conference on April 14, 2021
April 12, 2021
Vancouver, British Columbia--(Newsfile Corp. - April 12, 2021) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or the...
Via
Newsfile
< Previous
1
2
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.
Starting at $3.75
/
week.
Subscribe Today